[1] 孔蓓. HE染色和免疫组化染色在犬乳腺肿瘤诊断中的应用[D]. 杨凌:西北农林科技大学, 2015.
KONG B. The application of HE staining and immunohistochemical staining in the diagnosis of canine mammary tumors[D]. Yangling:Northwest A&F University, 2015. (in Chinese)
[2] RUGGERI B A, CAMP F, MIKNYOCZKI S. Animal models of disease:pre-clinical animal models of cancer and their applications and utility in drug discovery[J]. Biochem Pharmacol, 2014, 87(1):150-161.
[3] LIU D L, XIONG H, ELLIS A E, et al. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer[J]. Cancer Res, 2014, 74(18):5045-5056.
[4] QUEIROGA F L, RAPOSO T, CARVALHO M I, et al. Canine mammary tumours as a model to study human breast cancer:most recent findings[J]. In Vivo, 2011, 25(3):455-465.
[5] OZMEN O, KUL S, RISVANLI A, et al. Somatic SNPs of the BRCA2 gene at the fragments encoding RAD51 binding sites of canine mammary tumors[J]. Vet Comp Oncol, 2017, 15(4):1479-1486.
[6] RIVERA P, VON EULER H. Molecular biological aspects on canine and human mammary tumors[J]. Vet Pathol, 2011, 48(1):132-146.
[7] QIN C H, ZHU S P, TIAN J. New optical molecular imaging systems[J]. Curr Pharm Biotechnol, 2010, 11(6):620-627.
[8] PYSZ M A, GAMBHIR S S, WILLMANN J K. Molecular imaging:current status and emerging strategies[J]. Clin Radiol, 2010, 65(7):500-516.
[9] XIN J, ZHAN Y H, LIU M H, et al. ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo[J]. Cancer Lett, 2013, 336(2):260-269.
[10] THURBER G M, YANG K S, REINER T, et al. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo[J]. Nat Commun, 2013, 4:1504.
[11] NISHIMURA R, OKAMOTO N, SATOU M, et al. HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimens[J].Diagn Cytopathol, 2016, 44(4):274-279.
[12] RASHID O M, TAKABE K. Animal models for exploring the pharmacokinetics of breast cancer therapies[J]. Expert Opin Drug Metab Toxicol, 2015, 11(2):221-230.
[13] 殷小涛, 李方龙,金一鹏,等. 稳定表达hSPRY/Luc的人膀胱癌细胞株裸鼠皮下移植瘤模型的建立[J]. 细胞与分子免疫学杂志, 2017, 33(3):337-341.
YIN X T, LI F L, JIN Y P, et al. Establishment of a human bladder cancer cell line stably co-expressing hSPRY2 and luciferase genes and its subcutaneous tumor xenograft model in nude mice[J]. Chinese Journal of Cellular and Molecular Immunology, 2017, 33(3):337-341. (in Chinese)
[14] SAMUEL R. Spontaneous development of neoplasms in severe combined immunodeficient mice[J].SAGE Open Med Case Rep, 2015, 3:2050313X14568698.
[15] SONZOGNI-DESAUTELS K, KNAPP D W, SARTIN E, et al. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours[J]. Vet Comp Oncol, 2011, 9(3):161-171.
[16] QI B X, CHEN Y J, SU R, et al. Establishment of insect cell lines expressing green fluorescent protein on cell surface based on AcMNPV GP64 membrane fusion characteristic[J]. Cytotechnology, 2017, 69(5):775-783.
[17] HUANG C, LAN W J, WANG F F, et al. Establishment of a human breast cancer model by fusion PCR for in vivo and in vitro fluorescence imaging of human breast cancer[J]. DNA Cell Biol, 2017, 36(1):50-57.
[18] BURD C E, SORRENTINO J A, CLARK K S, et al. Monitoring tumorigenesis and senescence in vivo with a p16INK4a-luciferase model[J]. Cell, 2013, 152(1-2):340-351.
[19] TSENG C E, CHEN C H, CHEN S J, et al. Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor:a case report and review of the literature[J].Int J Clin Exp Pathol, 2014, 7(3):1212-1217.
[20] CACERES G, ZHU X Y, JIAO J A, et al. Imaging of luciferase and GFP-transfected human tumours in nude mice[J]. Luminescence, 2003, 18(4):218-223.
[21] OLIVIER T, GASTAUD L, MASCHI C, et al. Metastasis to unusual sites[J].Bull Cancer, 2014, 101(2):203-210. |